Presented below is information related to the purchases of common stock by Lilly Company during 2014.\nCost Fair Value (at purchase date) (at December
Presented below is information related to the purchases of common stock by Lilly Company during 2014.
\r\nCost Fair Value (at purchase date) (at December 31)
\r\nInvestment in Arroyo Company stock $100,000 $ 80,000
\r\nInvestment in Lee Corporation stock 250,000 300,000
\r\nInvestment in Woods Inc. stock 180,000 190,000
\r\nTotal $530,000 $570,000
\r\nInstructions
\r\n(Assume a zero balance for any Fair Value Adjustment account.)
\r\n(a) What entry would Lilly make at December 31, 2014, to record the investment in Arroyo Company stock if it chooses to report this security using the fair value option?
\r\n(b) What entry would Lilly make at December 31, 2014, to record the investment in Lee Corporation, assuming that Lilly wants to classify this security as available-for-sale? This security is the only available-for-sale security that Lilly presently owns.
\r\n(c) What entry would Lilly make at December 31, 2014, to record the investment in Woods Inc., assuming that Lilly wants to classify this investment as a trading security?